Dianthus Therapeutics (DNTH) Non-Current Assets: 2017-2025
Historic Non-Current Assets for Dianthus Therapeutics (DNTH) over the last 6 years, with Sep 2025 value amounting to $163.6 million.
- Dianthus Therapeutics' Non-Current Assets rose 145.09% to $163.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.6 million, marking a year-over-year increase of 145.09%. This contributed to the annual value of $93.1 million for FY2024, which is 4664.79% up from last year.
- Per Dianthus Therapeutics' latest filing, its Non-Current Assets stood at $163.6 million for Q3 2025, which was up 161.91% from $62.5 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Non-Current Assets registered a high of $163.6 million during Q3 2025, and its lowest value of $1.0 million during Q3 2023.
- Its 3-year average for Non-Current Assets is $52.4 million, with a median of $62.5 million in 2025.
- As far as peak fluctuations go, Dianthus Therapeutics' Non-Current Assets crashed by 96.85% in 2023, and later soared by 6,516.35% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Non-Current Assets (Quarterly) stood at $1.1 million in 2022, then surged by 81.43% to $2.0 million in 2023, then surged by 4,664.79% to $93.1 million in 2024, then surged by 145.09% to $163.6 million in 2025.
- Its Non-Current Assets was $163.6 million in Q3 2025, compared to $62.5 million in Q2 2025 and $77.6 million in Q1 2025.